6.
Kaye D
. The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications. Philos Ethics Humanit Med. 2019; 14(1):11.
PMC: 6731584.
DOI: 10.1186/s13010-019-0081-8.
View
7.
Gold R, Bunce A, Cowburn S, Dambrun K, Dearing M, Middendorf M
. Adoption of Social Determinants of Health EHR Tools by Community Health Centers. Ann Fam Med. 2018; 16(5):399-407.
PMC: 6131002.
DOI: 10.1370/afm.2275.
View
8.
Federspiel J, Anstrom K, Xian Y, McCoy L, Effron M, Faries D
. Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention. JAMA Cardiol. 2016; 1(6):655-65.
DOI: 10.1001/jamacardio.2016.1783.
View
9.
Gianfrancesco M, Goldstein N
. A narrative review on the validity of electronic health record-based research in epidemiology. BMC Med Res Methodol. 2021; 21(1):234.
PMC: 8549408.
DOI: 10.1186/s12874-021-01416-5.
View
10.
Rao S, Hess C, Barham B, Aberle L, Anstrom K, Patel T
. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014; 7(8):857-67.
DOI: 10.1016/j.jcin.2014.04.007.
View
11.
Snowden J, Lyndon A, Kan P, Ayadi A, Main E, Carmichael S
. Severe Maternal Morbidity: A Comparison of Definitions and Data Sources. Am J Epidemiol. 2021; 190(9):1890-1897.
PMC: 8579027.
DOI: 10.1093/aje/kwab077.
View
12.
Federspiel J, Wein L, Addae-Konadu K, Darwin K, Talamo L, Myers E
. Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines. J Thromb Haemost. 2020; 19(3):830-838.
PMC: 7925427.
DOI: 10.1111/jth.15218.
View
13.
Stein P, Henry J
. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995; 108(4):978-81.
DOI: 10.1378/chest.108.4.978.
View
14.
Marill M
. Getting To The Heart Of America's Maternal Mortality Crisis. Health Aff (Millwood). 2021; 40(12):1824-1829.
DOI: 10.1377/hlthaff.2021.01702.
View
15.
Pettker C, Grobman W
. Obstetric Safety and Quality. Obstet Gynecol. 2015; 126(1):196-206.
DOI: 10.1097/AOG.0000000000000918.
View
16.
Gingrey J
. Maternal Mortality: A US Public Health Crisis. Am J Public Health. 2020; 110(4):462-464.
PMC: 7067092.
DOI: 10.2105/AJPH.2019.305552.
View
17.
Menard M, Main E, Currigan S
. Executive summary of the reVITALize initiative: standardizing obstetric data definitions. Obstet Gynecol. 2014; 124(1):150-153.
DOI: 10.1097/AOG.0000000000000322.
View
18.
Jay C, Schold J
. Measuring transplant center performance: The goals are not controversial but the methods and consequences can be. Curr Transplant Rep. 2017; 4(1):52-58.
PMC: 5616160.
DOI: 10.1007/s40472-017-0138-9.
View
19.
Venkatesh K, Strauss R, Grotegut C, Heine R, Chescheir N, Stringer J
. Machine Learning and Statistical Models to Predict Postpartum Hemorrhage. Obstet Gynecol. 2020; 135(4):935-944.
PMC: 7236480.
DOI: 10.1097/AOG.0000000000003759.
View
20.
Rosenstein M, Chang S, Sakowski C, Markow C, Teleki S, Lang L
. Hospital Quality Improvement Interventions, Statewide Policy Initiatives, and Rates of Cesarean Delivery for Nulliparous, Term, Singleton, Vertex Births in California. JAMA. 2021; 325(16):1631-1639.
PMC: 8080226.
DOI: 10.1001/jama.2021.3816.
View